PE-22-28
Also known as: PE22-28 · Spadin analog
A spadin analog studied for rapid antidepressant-like effects, working through TREK-1 potassium channel modulation.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~2–4 hours
100–500 mcg
Subcutaneous injection or intranasal
Mechanism of Action
Blocks TREK-1 potassium channels to enhance serotonergic and noradrenergic neurotransmission, producing fast-acting mood elevation.
Key Research Areas
Frequently Asked Questions
What is PE-22-28?▾
How does PE-22-28 work?▾
What is the recommended dosage for PE-22-28?▾
What is the half-life of PE-22-28?▾
Is PE-22-28 FDA approved?▾
Ready to get started with PE-22-28?
Order from our COA-verified partner — free US shipping, pharmaceutical-grade quality.
Research Disclaimer
The information provided about PE-22-28 is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.